NGEN
NervGen Pharma Corp.
1.80$
+1.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +5.8% | -0.7% | -60.9% | -2.6% | +8.0% | -12.2% | +1.1% | -0.3% | -314.4% | – | +1.0% | – | |
| – | – | – | – | – | – | – | – | – | – | -147.3% | – | – | |
| – | +222.4% | +11.6% | +27.7% | +16.3% | +3.9% | -31.5% | -13.4% | +63.7% | +47.8% | -24.8% | +64.0% | – | |
| – | – | – | – | – | – | +30.4% | +30.2% | -54.1% | +62.2% | -4.7% | +61.4% | – | |
| – | +43.6% | +2.1% | +21.1% | +20.4% | -5.8% | -11.8% | +8.4% | -5.0% | +90.3% | -34.9% | +63.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -125.1% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.